Sejin Lee

Prof. Sejin Lee

Jeonbuk National University, Jeonju, Korea
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
Dong Jin KimDong Jin Kim
Dong Jin Kim
JSJeong Ho Song
Jeong Ho Song
JPJi-Hyeon Park
Ji-Hyeon Park
SKSojung Kim
Sojung Kim
SPSin Hye Park
Sin Hye Park
TAThe Information Committee of the Korean Gastric Cancer Association
The Information Committee of the Korean Gastric Cancer Association
Kim DJ, et al. J Gastric Cancer. 2024 Dec;25:e8. https://doi.org/10.5230/jgc.2025.25.e8

1 January 2020 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
JSJeong Ho Song
Jeong Ho Song
TSTaeil Son
Taeil Son
SLSejin Lee
Sejin Lee
SCSeohee Choi
Seohee Choi
MCMinah Cho
Minah Cho
WHWoo Jin Hyung
Woo Jin Hyung
Song JH, et al. J Gastric Cancer. 2020 Dec;20(4):431-441. https://doi.org/10.5230/jgc.2020.20.e36

6 May 2023 in Trials
Verified
Journal Article
Open access
PDF file
SLSejin Lee
Sejin Lee
SHSe Wung Han
Se Wung Han
MLMin Ro Lee
Min Ro Lee
CKChan-Young Kim
Chan-Young Kim
GHGi Won Ha
Gi Won Ha
Background: Incisional hernia following abdominal surgery is a frequent complication of midline laparotomy. This complication is strongly associated with the technique and material used for suture. While a monofilament absorbable suture is recommended to prevent incisional hernia, it can lead to suture loosening or surgical-knot breakage. Although barbed sutures can be an alternative suture material in abdominal fascial closure, evidence for its safety and effectiveness is lacking. Therefore, we designed a prospective randomized trial to evaluate the safety and efficacy of absorbable barbed sutures for midline fascia closure in minimally invasive surgery for colorectal and gastric cancers in comparison with conventional absorbable monofilament sutures. Methods: A total of 312 patients who underwent minimally invasive surgery for colorectal and gastric cancers will be randomly allocated to either the absorbable barbed or monofilament suture group for abdominal fascia closure in a 1:1 ratio. The primary outcome is incisional hernia rate within 3 years after surgery, as verified by physical examination and computed tomography. Postoperative complications, including surgical site infection, postoperative pain, and quality of life, will be compared between two groups as secondary outcomes. The investigator will examine the patients until discharge and at 6, 12, 18, 24, and 36 months postoperatively. Discussion: This is the first randomized controlled trial to compare absorbable barbed sutures with monofilament sutures for midline fascia closure in minimally invasive surgery. If absorbable barbed sutures demonstrate superior results to those of monofilament sutures, this type of suture material may be recommended as an alternative option for abdominal fascia closure. Trial registration: KCT0007069. Registered on January 30, 2023

31 May 2022 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
JSJeong Ho Song
Jeong Ho Song
HSHye Jung Shin
Hye Jung Shin
SLSejin Lee
Sejin Lee
SPSung Hyun Park
Sung Hyun Park
MCMinah Cho
Minah Cho
HKHyoungil Kim
Hyoungil Kim

1 January 2021 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
SCSeohee Choi
Seohee Choi
TSTaeil Son
Taeil Son
JSJeong Ho Song
Jeong Ho Song
SLSejin Lee
Sejin Lee
MCMinah Cho
Minah Cho
WHWoo Jin Hyung
Woo Jin Hyung
Choi S, et al. J Gastric Cancer. 2021 Jun;21(2):132-141. https://doi.org/10.5230/jgc.2021.21.e16

17 November 2021 in Cancers
Verified
Journal Article
Open access
PDF file
SLSejin Lee
Sejin Lee
JSJeong Ho Song
Jeong Ho Song
SPSung Hyun Park
Sung Hyun Park
MCMinah Cho
Minah Cho
YKYoo Min Kim
Yoo Min Kim
WHWoo Jin Hyung
Woo Jin Hyung
Background: Additional surgery after non-curative endoscopic submucosal dissection (ESD) may be excessive as few patients have lymph node metastasis (LNM). It is necessary to develop a risk stratification system for LNM after non-curative ESD, such as the eCura system, which was introduced in the Japanese gastric cancer treatment guidelines. However, the eCura system requires venous and lymphatic invasion to be separately assessed, which is difficult to distinguish without special immunostaining. In this study, we practically modified the eCura system by classifying lymphatic and venous invasion as lymphovascular invasion (LVI). Method: We retrospectively reviewed 543 gastric cancer patients who underwent radical gastrectomy after non-curative ESD between 2006 and 2019. LNM was evaluated according to LVI as well as size >30 mm, submucosal invasion ≥500 µm, and vertical margin involvement, which were used in the eCura system. Results: LNM was present in 8.1% of patients; 3.6%, 2.3%, 7.4%, 18.3%, and 61.5% of patients with no, one, two, three, and four risk factors had LNM, respectively. The LNM rate in the patients with no risk factors (3.6%) was not significantly different from that in patients with one risk factor (2.3%, p = 0.523). Among patients with two risk factors, the LNM rate without LVI was significantly lower than with LVI (2.4% vs. 10.7%, p = 0.027). Among patients with three risk factors, the LNM rate without LVI was lower than with LVI (0% vs. 20.8%, p = 0.195), although not statistically significantly. Based on LNM rates according to risk factors, patients with LVI and other factors were assigned to the high-risk group (LNM, 17.4%) while other patients as a low-risk group (LNM, 2.4%). Conclusions: Modifying the eCura system by classifying lymphatic and venous invasion as LVI successfully stratified LNM risk after non-curative ESD. Moreover, the high-risk group can be simply identified based on LVI and the presence of other risk factors.